Vaccine Platforms & Platform Variables
Source: Bioprocess Online
In this segment of our recent BioProcess Online Live! event Manufacturing Vaccines On COVID's Coattails, Christina Yi, Chief Operating Officer at Vaxxinity, vaccine commercialization expert Kimberly Murphy, and Valneva Chief Medical Officer Dr. Juan Carlos Jaramillo discuss vaccine platform differentiation and the fine line between proven technologies and today's new and diverse platforms for vaccine development. Audience members also weigh in with their takes on the most promising of the new vaccine technologies under FDA review.
View the full presentation on-demand here.
This website uses cookies to ensure you get the best experience on our website. Learn more